Pipra Company
Delirium is one of the largest issues in healthcare and is massively unaddressed. It represents a significantly higher cost than diabetes. Post-Operative Delirium (POD) is the most common post-surgical complication affecting 20% of patients over 60 with long-term consequences for patients and enormous costs to hospitals and insurers. Our CE-certified, A.I-driven clinical decision support software helps doctors identify high-risk patients prior to surgery. Highlighting high-risk patients allows for effective, cost-reducing measures to be implemented shown to decrease the incidence by 53%. We are currently live in 3 hospitals with 22 hospitals throughout Europe in our pipeline. Our advisory board includes 6 KOL’s from aroudn the world including in the U.S. from Johns Hopkins, Harvard and Cornell.
Industry:
mHealth
Headquarters:
Zürich, Zurich, Switzerland
Zip:
1-10
Founded Date:
2019-08-01
Employees Number:
1-10
Acquisitions Number:
7
Investors Number:
3625743
Total Funding:
3625743
Last Funding Date:
Seed
Last Funding Type:
john@pipra.ch
Register and Claim Ownership